PREDIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.617
EU - Europa 22.881
AS - Asia 6.480
SA - Sud America 686
AF - Africa 165
OC - Oceania 122
Continente sconosciuto - Info sul continente non disponibili 15
Totale 53.966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.330
IT - Italia 11.159
GB - Regno Unito 4.663
SG - Singapore 2.150
SE - Svezia 1.635
CN - Cina 1.527
DE - Germania 1.411
HK - Hong Kong 1.299
UA - Ucraina 751
RU - Federazione Russa 667
FR - Francia 634
FI - Finlandia 524
TR - Turchia 516
BR - Brasile 514
BG - Bulgaria 296
NL - Olanda 234
IN - India 220
ID - Indonesia 212
IE - Irlanda 152
CA - Canada 151
CH - Svizzera 139
AU - Australia 106
ES - Italia 87
IR - Iran 87
JP - Giappone 80
VN - Vietnam 79
BE - Belgio 74
BZ - Belize 73
LT - Lituania 65
EG - Egitto 64
DK - Danimarca 58
AT - Austria 51
CZ - Repubblica Ceca 51
EC - Ecuador 50
MY - Malesia 50
MX - Messico 40
PK - Pakistan 39
PL - Polonia 39
RO - Romania 37
ZA - Sudafrica 36
AR - Argentina 34
KR - Corea 29
TH - Thailandia 29
PT - Portogallo 27
IQ - Iraq 25
VE - Venezuela 25
GR - Grecia 24
TW - Taiwan 22
PE - Perù 21
HU - Ungheria 16
NZ - Nuova Zelanda 16
BD - Bangladesh 14
CL - Cile 13
EU - Europa 13
IL - Israele 13
MA - Marocco 13
PH - Filippine 13
RS - Serbia 13
SA - Arabia Saudita 13
SM - San Marino 13
CO - Colombia 12
UZ - Uzbekistan 10
AZ - Azerbaigian 9
ET - Etiopia 9
NG - Nigeria 9
NO - Norvegia 9
KW - Kuwait 8
LK - Sri Lanka 7
MT - Malta 7
PA - Panama 7
UY - Uruguay 7
DZ - Algeria 6
EE - Estonia 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
DO - Repubblica Dominicana 5
JO - Giordania 5
PY - Paraguay 5
TN - Tunisia 5
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
CR - Costa Rica 4
GH - Ghana 4
HR - Croazia 4
KE - Kenya 4
OM - Oman 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
HN - Honduras 3
KZ - Kazakistan 3
ME - Montenegro 3
MK - Macedonia 3
BA - Bosnia-Erzegovina 2
BT - Bhutan 2
BY - Bielorussia 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 53.939
Salva come PNG Salva come JPEG
Città #
Southend 3.321
Santa Clara 3.096
Fairfield 2.253
Chandler 1.624
Woodbridge 1.600
Houston 1.517
Ashburn 1.482
Jacksonville 1.354
Hong Kong 1.249
Singapore 1.211
Dearborn 1.130
Nyköping 888
Ann Arbor 859
Seattle 826
Wilmington 801
London 795
Rome 789
Milan 782
Cambridge 686
Beijing 429
Princeton 325
Naples 319
Helsinki 301
Sofia 283
Bologna 274
Modena 257
Eugene 253
San Diego 251
New York 245
Munich 227
Palermo 220
Redwood City 217
Moscow 208
Izmir 207
Turin 200
Jakarta 190
Bremen 186
San Jose 178
Bari 134
Florence 134
Catania 121
Frankfurt am Main 121
Padova 120
Shanghai 116
Dublin 114
Fremont 97
Parma 96
Council Bluffs 95
Des Moines 93
Verona 92
Boardman 87
Albuquerque 76
Belize City 73
Falls Church 70
Las Vegas 70
Genoa 67
Dong Ket 61
Brescia 55
Toronto 54
Dallas 53
Nanjing 53
Pescara 53
Norwalk 52
Los Angeles 50
Nuremberg 50
Cagliari 47
Hefei 45
Brussels 41
Cairo 41
Portsmouth 41
Reggio Nell'emilia 41
Guangzhou 40
Perugia 40
Reggio Emilia 40
Paris 39
Torino 39
Odense 38
Brno 37
Kunming 37
Saint Louis 36
Treviso 36
Chicago 35
Ottawa 35
São Paulo 35
Lauterbourg 34
Menlo Park 34
Napoli 34
Bergamo 33
Caserta 33
Pavia 33
Philadelphia 31
Mumbai 30
Pisa 30
Columbus 29
Düsseldorf 28
Istanbul 28
Phoenix 28
Salerno 28
Grafing 27
Ankara 26
Totale 34.519
Salva come PNG Salva come JPEG
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.274
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.020
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 920
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 785
Gestione del Covid-19 in età pediatrica: documento di consenso 656
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 597
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 589
Effetti degli interferenti endocrini su crescita e sviluppo puberale 574
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 425
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 416
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 386
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 350
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 342
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 338
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 298
Childhood obesity and environmental pollutants: a dual relationship 297
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 294
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 293
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 285
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 285
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 278
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 274
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 272
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 272
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 268
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 267
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 261
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 257
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 256
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 256
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 255
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 253
L’ipercolesterolemia familiare: terapia farmacologica 247
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 246
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 245
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 240
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 235
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 234
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. 229
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 226
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 220
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 220
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 219
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 213
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 212
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 211
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 210
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 209
Hypercholesterolemia in Childhood 209
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 208
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 207
Confocal microscopy: Improving our understanding of nevogenesis 205
Novel insights on the treatment of hypercholesterolemia 204
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 204
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 204
Brain-derived neurotrophic factor and epilepsy: a systematic review 202
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 202
Obesity in pediatric age: The analysis of genomic rearrangements 202
Rhabdomyoma of a rare type in a child: Case report and literature review 201
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 199
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 198
Endocrine Disrupting Chemicals and Type 1 Diabetes 198
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 197
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 196
High basal serum allopregnanolone levels in overweight girls 196
Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus 196
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 196
Approaches to dyslipidemia treatment in children and adolescents. 193
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 193
Iper CPKemia, non solo miopatie 193
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 190
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 190
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 189
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 188
High serum allopregnanolone levels in girls with precocious puberty 186
COVID-19 and Type 1 Diabetes: Concerns and Challenges 186
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 185
Evaluation and management of hyperlipidemia in children and adolescents. 185
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 182
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 181
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 181
Low-density lipoprotein oxidizability in children with chronic renal failure 180
Pharmacological treatment of obesity in children and adolescents: present and future. 180
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 180
Thyroid function in Down syndrome 180
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 178
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 177
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 177
Low serum allopregnanolone levels in girls with precocious pubarche 176
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 176
Gli interferenti endocrini 176
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 175
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 175
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 173
Unexpected phenotype in a boy with trisomy of the SHOX gene. 173
In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders 172
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 171
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 171
Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. 171
Continuous subcutaneous insulin infusion in Italy: third national survey 169
Totale 29.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.101 0 0 0 0 0 0 0 0 0 351 487 263
2020/20217.088 611 223 516 833 729 541 952 630 405 694 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202512.117 572 469 440 1.066 2.521 2.130 1.193 874 1.973 879 0 0
Totale 54.779